Each Film-coated tablet contains Trimetazidine Dihydrochloride BP 20 mg.
Angimet MR Tablet:
Each Modified Release tablet contains Trimetazidine Dihydrochloride BP 35 mg.
Dosage & Administration
Prophylactic treatment of episodes of angina pectoris and sequelae of infarction.
Angimet Tablet: One tablet three times daily.
Angimet MR Tablet: One tablet two times daily.
Hypersensitivity to Trimetazidine Dihydrochloride.
Studies in animals have not demonstrated a teratogenic effect. However, in the absence of clinical data and for safety reasons, prescription should be avoided during pregnancy.
Lactation:In the absence of data, breastfeeding is not recommended during treatment.
No drug interactions so far have been reported. In particular, no interactions have been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparations.
Rare cases of gastrointestinal disorders, nausea and vertigo. The side effects are mild and non-specific.
Angimet Tablet: Each box contains 5X10 tablets in Alu-Alu blister pack.
Angimet MR Tablet: Each box contains 3X10 tablets in Alu-Alu blister pack.